semaglutide and anger GLP-1 medicine improves liver health independent of weight loss, according to a new Sinai Health & U of T Medicine study ➡️ uoft.me/cjP The Boom in New Weight

Resources The computational study for present work was performed in High Performance Super Computing facility, Param Shivay of 837 TFLOPS capacity with Intel(R) Xeon(R) Gold 6148 CPU @ 2.40 GHz and 40 CPU per node

In January of 2024, semaglutide and tirzepatide were both on FDA's list of drugs in shortage, which meant compounding pharmacies are now able to step in and provide compounded versions of GLP-1 meds

The Precision Peptide Genetic Test analyzes variants like GLP1R rs6923761 and GIPR rs1800437 that influence how your body responds to semaglutide and other GLP-1 agents

47 In patients with overweight or obesity without diabetes, the Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) trial showed that tirzepatide 15 mg weekly led to a mean body weight reduction of 20.9% after 72 weeks of treatment, compared with 3.1% with placebo